Agranulocytose induite par la dapsone prescrite pour une dermatite herpétiforme

Annales de Dermatologie et de Venereologie

Volumn 123, Issue 5, 1996, Pages 328-330

  Machet, L ^a   Callens, A ^a   Mercier, E ^a   Gargot, S ^a   Lorette, G ^a   Vaillant, L ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE;

ADULT; AGRANULOCYTOSIS; ARTICLE; CASE REPORT; DERMATITIS HERPETIFORMIS; HUMAN; MALE;

AGRANULOCYTOSIS; DAPSONE; DERMATITIS HERPETIFORMIS; FEVER; HUMANS; MALE; MIDDLE AGED;

EID: 0029945714     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Coleman MD. Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. Br J Dermatol 1993;129:507-13.
2. Bordessoule D, Liozon E, Cransac M, Bonnetblanc JM, Vidai E, Weinbreck P et al. Effets hématologiques de la dapsone (Disulone®). Rev Med Interne 1989;10:531-6.
3. Liozon F, Fourgnaud-Gaillard S, Bordessoule D, et al. Agranulocytoses à la dapsone. A propos de 3 observations. Revue de la littérature. Ann Med Interne 1988;139:469-75.
4. Woodbury GR, Fried W, Ertle JO, Malkinson FD. Dapsone-associated agranulocytosis and severe anemia in a patient with leucocytoclastic vasculitis. J Am Acad Dermatol 1993;28:781-3.
5. Miyagawa S, Shiomi Y, Fukumoto T, Ishii Y, Shirai T. Recombinant granulocyte colony-stimulating factor for dapsone-induced agranulocytosis in leukocytoclastic vasculitis. J Am Acad Dermatol 1993;28:659-61.
6. Demuynk H, Zachee P, Verhoef GE, Schetz M, Van den Berghe B, Lauwers P et al. Risks of rhG-CSF treatment in drug-induced agranulocytosis. Ann Hematol 1995;70:143-78.
7. Genet P, Pulik M, Lionnet F, Bremont C. Agranulocytose induite par les antithyroïdiens : efficacité des facteurs de croissances hématopoïétiques. Ann Endocrinol 1994;55:39-42.
8. Ognibene AJ. Agranulocytosis due to dapsone. Ann Intern Med 1970;75:521-4.
9. Hörnstern P, Keisu M, Wiholm BE, The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988. Arch Dermatol 1990;126:919-22.
10. Coleman MD, Simpson J, Jacobus DP. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro IV: implications for the development of agranulocytosis. Biochem Pharmacol 1994;48:1349-54.
11. Duhra P, Charles-Holmes R. Linear IgA disease with haemorragic pompholyx and dapsone-induced neutropenia. Br J Dermatol 1991;125:172-4.
12. Cockburn EM, Wood SM, Waller PC, Bleehen SS. Dapsone-induced agranulocytosis: spontaneous reporting data. Br J Dermatol 1993;128:702-3.